Electric fields and radiation team up against pancreas cancer
NCT ID NCT05679674
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 36 times
Summary
This study tests whether adding a device that sends low-intensity electric fields (tumor treating fields) to standard radiation therapy can slow tumor growth in people with locally advanced pancreas cancer. About 48 participants will receive radiation for 5 days and use the device at least 18 hours daily until their disease worsens. The goal is to see if this combination improves how long the cancer stays under control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Miami Cancer Institute at Baptist Health, Inc.
RECRUITINGMiami, Florida, 33176, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stereotactic ablative body radiation (SABR) and tumor treating fields (TTF) device
What this could lead to
If successful, this combination could slow tumor growth and extend survival for people with locally advanced pancreas cancer.
What could go wrong
This is a small early-phase trial with only 48 participants, so results may not apply widely. The TTF device must be worn 18+ hours daily, which may be burdensome, and side effects from radiation or the device could occur.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.